Want to know the current price of Bristol-Myers Squibb and what’s next for BMY stock? On this page we share the latest news about Bristol Myers Squibb and give advice on buying shares. You can also view the latest Bristol-Myers Squibb stock forecast for 2021 and 2022 from our experts.
Should I buy or sell Bristol-Myers Squibb shares today? To what levels can the shares of this company rise in a year, two, three? How much will Bristol-Myers Squibb be worth in 2021, 2022, 2023? We have been making currency rate forecasts for a long time, and we can also predict the behavior of the stock market using technical analysis and simple indicators.
We also take into account the technical, fundamental analysis of stocks, the news background, the general geopolitical situation in the world and other, smaller factors. The stock forecasts indicate target levels for BMY stock, both up and down.
Bristol-Myers Squibb Forecast for 2022 and 2023
Quotes of Bristol-Myers Squibb continue to move within a slight decline and an upward channel. The moving averages indicate a short-term bullish trend for BMY shares. Prices have broken through the area between the signal lines down, which indicates pressure from sellers of securities and a likely continuation of the decline in the near future. At the time of publication of the forecast, the share price is 65.81 per share. As part of the forecast, we should expect an attempt to continue the development of the decline and a test of the support level near the area of 60.05. Further, the price bounces up and the continued rise in the value of securities. The potential target of such a movement in shares is the area above the level of 80.05 already in 2021, 2022, 2023.
An additional signal in favor of the growth of Bristol Myers Squibb quotes will be a test of the support line on the relative strength index (RSI). The second signal will be a rebound from the lower border of the bullish channel. Cancellation of the option to raise the price of Bristol-Myers Squibb shares will be a fall and a breakdown of the level of 55.05. This will indicate a breakdown of the support area and the lower border of the channel, in which case we can consider a continuation of the decline in securities to the area at the level of 46.55. It is worth waiting for confirmation of the rise in shares with a breakdown of the resistance area and closing above the level of 73.55, which will indicate a breakdown of the upper limit of the bullish channel, which will be a very strong signal in favor of the development of a bullish trend in shares.
Bristol-Myers Squibb Forecast for 2022 and 2023 suggests the development of a decline and a test of the support area near the level of 60.05. Where should we expect a rebound and an attempt to continue the rise of shares in the area above the level of 80.05. In favor of the growth of securities, a test of the trend line on the relative strength index (RSI) will come out. Cancellation of the BMY rise option will be a fall and a breakdown of the level of 55.05. This will indicate a breakdown of the lower border of the channel and a continuation of the fall in value to the area below the level of 46.55.
